KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Total Current Liabilities (2016 - 2026)

Emergent BioSolutions has reported Total Current Liabilities over the past 17 years, most recently at $148.7 million for Q1 2026.

  • For Q1 2026, Total Current Liabilities rose 32.89% year-over-year to $148.7 million; the TTM value through Mar 2026 reached $148.7 million, up 32.89%, while the annual FY2025 figure was $132.2 million, 18.6% down from the prior year.
  • Total Current Liabilities for Q1 2026 was $148.7 million at Emergent BioSolutions, up from $132.2 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $1.2 billion in Q4 2022 and troughed at $111.9 million in Q1 2025.
  • A 5-year average of $443.6 million and a median of $264.4 million in 2022 define the central range for Total Current Liabilities.
  • Biggest five-year swings in Total Current Liabilities: soared 387.84% in 2023 and later crashed 82.24% in 2025.
  • Year by year, Total Current Liabilities stood at $1.2 billion in 2022, then tumbled by 47.0% to $651.3 million in 2023, then crashed by 75.07% to $162.4 million in 2024, then decreased by 18.6% to $132.2 million in 2025, then rose by 12.48% to $148.7 million in 2026.
  • Business Quant data shows Total Current Liabilities for EBS at $148.7 million in Q1 2026, $132.2 million in Q4 2025, and $136.5 million in Q3 2025.